F rom the multitude of proteins with bound prosthetic groups, metal clusters, or cofactors, the soluble c-type cytochromes were among the first to be characterized, probably because of their spectral visibility and unusual stability. The pathway for their biosyntheses, nevertheless, remains to be filled in as do the mechanistic details of holoprotein formation. Historically, many assumed, perhaps naively, that the assembly of most metalloor other cofactor-containing proteins occurred without catalysis, relying on spontaneity, and this idea was reinforced by the facile in vitro formation of stable FeS clusters and uncatalyzed in vitro reconstitution of metalloproteins like plastocyanins or ferredoxins from inorganic ions and apoproteins. Today, we appreciate that synthesis of a functional holoprotein is a biochemical pathway with multiple catalyzed steps that ensure selectivity and specificity. Because the c-type cytochromes contained covalently bound heme, the need for catalysis for their biosynthesis was always appreciated and indeed genetic analyses over the last 30 years have revealed a striking diversity of pathways, of which the so-called system I, II, and III pathways are the most common (reviewed in refs. 1 and 2). Their unifying features include a requirement for reductant and a heme binding component. In this issue of PNAS, Frawley and Kranz (3) demonstrate that the conserved WWD motif of the CcsBA protein of the system II pathway is a heme binding platform on a transmembrane protein that serves to deliver heme from the bacterial cytoplasm to the periplasm.
Assembly factors tend to be lowabundance proteins, and when they are multispanning membrane proteins that form a complex, the technical challenges in distinguishing their specific biochemical functions are considerable. Frawley and Kranz (3) identified naturally occurring fusions of the CcsA and CcsB proteins of the system II pathway in several bacterial genomes, which facilitated functional analysis of the ''dimer'' (Fig. 1) . The combination of in vitro biochemistry and heterologous functional assay in their work provides a satisfying answer to a longstanding question concerning the role of these signature proteins in one important pathway of cytochrome biogenesis.
The first cytochrome assembly factors to be identified were the cytochrome c/heme lyases (CCHLs) of animal and fungal mitochondria (reviewed in ref. 4) . Surprisingly, given the ancient prevalence of the c-type cytochromes and the endosymbiotic origin of mitochondria, homologues of the CCHLs were not found in bacterial genomes. Instead, genetic analyses identified multicomponent cytochrome c maturation (ccm) or cytochrome c synthesis (ccs) pathways in bacteria and chloroplasts, corresponding to the system I and II machineries (reviewed in refs. 1 and 5). The machineries are modular, consisting of components that work on the cysteinyl thiols of the apocytochrome and others that handle heme (discussed in ref. 6 ).
Because the c-type cytochromes are located in a different compartment from the site of synthesis of the apoprotein and heme, their maturation pathways demand a mechanism for translocation of heme across the bioenergetic membrane. One formal possibility is that heme translocation is coupled to translocation of the polypeptide, but several studies argued against this model. In system I, the apoproteins accumulate in the periplasm when heme attachment is blocked and periplasmic reactions involving thiol chemistry on the apoprotein and heme chemistry on a heme chaperone are required for cytochromes biogenesis (7) (8) (9) . The same is true for system II where pulse-chase studies established heme attachment as the last (posttranslocation) step in cytochrome maturation in chloroplasts and genetic analyses implicated lumen-side reactions for preparation of the apoprotein substrate (10, 11) . Therefore, it was always assumed that a subset of the Ccm and Ccs factors must function in transmembrane heme delivery. Nevertheless, the chemical requirements for heme transfer were not known.
Sequence analysis of system I CcmC and CcmF and system II CcsA had identified a tryptophan-rich region, subsequently named the WWD motif, as a possible heme binding platform (refs. 5 and 12 and reviewed in ref. 13) , and therefore they were choice candidates for catalysis of the heme transport step and/or the lyase step where the cysteinyl thiols add to the heme vinyls. In system I, CcmC has been implicated as a subunit of an ABC type transporter for transmembrane heme delivery, whereas CcmF is implicated in the lyase step. The work of Kranz and coworkers (3, 14) demonstrates CcsA participation in both transport and heme attachment without the necessity of an intermediate heme chaperone.
Comparison of the bacterial and chloroplast system II proteins allows the work on heme delivery across the bacterial membrane to be extended to the thylakoid membrane. Mutational analysis in Chlamydomonas indicated that plastid-encoded CcsA functioned in a 200-kDa membrane complex together with nucleus-encoded Ccs1 (15, 16) . Topological reporters place 2 conserved histidine residues within the membrane on the cytoplasmic side and 2 others on the periplasmic side in juxtamembrane loops flanking the WWD motif in both the dimeric complex of chloroplasts and the single subunit fusion CcsBA polypeptide (Fig. 1) . Frawley and Kranz (3) show that within membrane histidines on the cytoplasmic side serve as ligands to the heme iron to protect it from oxidation during transfer to a more oxidizing compartment, exactly analogous to the function of the proximal histidine in myoglobin. The extramembrane histidines on the periplasmic side are proposed to bind heme tightly on the WWD platform as it is presented to the apocytochrome, perhaps providing a driving force for transfer.
Given that CcsBA can function independently of other Ccs or Ccm components in a heterologous in vivoreconstituted system for cytochrome c assembly, it must perform the function of both heme transport across the membrane and catalysis of thioether bond formation. Catalysis results from proximity and orientation of the 2 substrates (heme and the cysteinyl thiols) in a complex between the apocytochrome and the extramembrane WWD-containing domain of CcsA with product formation driven by the stability of holocytochrome relative to the apoform. This study (3) raises the question of the importance of CcmE, the diagnostic and widespread component of the system I pathway. Is CcmE important for regulated allocation of heme to multiple cytochromes? This view is supported by the more effective use of cytoplasmic heme in a situation of reduced availability by the system I components vs. system II components (14) . Alternatively, CcmE function might be critical in a situation where the substrates for the lyase are in a suboptimal redox environment. For instance, heme could be held by CcmE until the apocytochrome is available in the appropriate state of reduction.
How heme might be delivered to the CCHLs in the mitochondrial intermembrane space remains a puzzle. The terminal step of heme biosynthesis is associated with the mitochondrial inner membrane on the matrix side (reviewed in ref. 4) . For plant mitochondria, where system I operates, the pathway for heme delivery and heme attachment is likely analogous to the Ccm system. However, there are no homologues of the Ccm or Ccs molecules in animal and fungal genomes. Yet, heme must move from ferrochelatase, not only to the intermembrane space for cytochromes c and c 1 synthesis but also to many other compartments containing heme proteins (reviewed in ref. 17) . Have mitochondrial heme exporters eluded genetic identification because of redundancy? Or is the mechanism of export unconventional? In the case of the CCHLs, there is the possibility of substrate channeling from the ferrochelatase to the CCHLs (by analogy to channeling of protoporphyrin IX from protoporphyrinogen oxidase to ferrochelatase), but for loading of extramitochondrial hemes in the P450s, peroxidases and regulators in the nucleus, a transport system must be required. Perhaps we must think outside of the box of conventional integral membrane protein transporters and channels and consider lipid-based trafficking mechanisms.
